Case report: Sleep wake cycle disorder and agitation associated with levetiracetam in an elderly patient with traumatic brain injury

British Journal of Medical Practitioners

Volumn 5, Issue 3, 2012, Pages

  Nair, C V ^a   Kadies, M A ^b  

^a Rehabilitation Medicine   (United Kingdom)

^b Devonshire Centre for Neurorehabilitation   (United Kingdom)

Author keywords

Agitation; Levetiracetam; Sleep wake cycle disorder; Traumatic brain injury

Indexed keywords

CLOBAZAM; ETIRACETAM; VALPROIC ACID;

AGED; AGITATION; ARTICLE; CASE REPORT; COGNITIVE DEFECT; COGNITIVE REHABILITATION; CONFUSION; DAILY LIFE ACTIVITY; DISORIENTATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPHASIA; FALLING; HOSPITAL ADMISSION; HUMAN; HYPONATREMIA; MALE; MYOCLONUS; REHABILITATION CENTER; SEIZURE; SIDE EFFECT; SLEEP DISORDER; SLEEP WAKE CYCLE DISORDER; SLEEP WAKING CYCLE; TRAUMATIC BRAIN INJURY;

EID: 84868268349     PISSN: 17578515     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Susman M, DiRusso SM, Sullivan T. Traumatic brain injury in the elderly: increased mortality and worse functional outcome at discharge despite lower injury severity. J Trauma. 2002 Aug; 53(2):219-23.
2. Goldstein FC, Levin HS, Presley RM. Neurobehavioural consequences of closed head injury in older adults. J Neurol Neurosurg Psychiatry. 1994 Aug; 57(8):961-6.
3. Lye TC, Shores EA. Traumatic brain injury as a risk factor for Alzheimer's disease: a review. Neuropsychol Rev. 2000 Jun; 10(2):115-29.
4. Verma A, Anand V, Verma NP. Sleep disorders in chronic traumatic brain injury. J Clin Sleep Med. 2007 Jun 15; 3(4):357-62.
5. Patten SB, Lauderdale WM. Delayed sleep phase disorder after traumatic brain injury. J Am Acad Child Adolesc Psychiatry. 1992 Jan; 31(1):100-2.
6. Nott MT, Chapparo C, Baguley I. Agitation following traumatic brain injury: an Australian sample. JBrain Inj. 2006 Oct;20(11):1175-82.
7. Fleminger S, Greenwood RJ, Oliver DL. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003299.
8. Li Pi, Shan RS, Ashworth NL. Comparison of lorazepam and zopiclone for insomnia in patients with stroke and brain injury: a randomized, crossover, double-blinded trial. Am J Phys Med Rehabil 2004;83:421-427.
9. Mula M, Trimble MR, Yuen A. Psychiatric adverse events during levetiracetam therapy. Neurology. 2003 Sep 9;61(5):704-6.
10. Aggarwal A, Dutt D, Sharma RC. Probable psychosis associated with Levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):274-5.
11. Cicolin A, Magliola U, Giordano A. Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers. Epilepsia. 2006 Jan;47(1):82-5.
12. Yilmaz H. Comparison of motor activity and sleep in patients with complex partial seizures on levetiracetam treatment and a group of healthy subjects. Behav Neurol. 2007;18(3):165-70.
13. Siniscalchi A, L Gallelli L, De Fazio S. Psychic Disturbances Associated with Sodium Valproate Plus Levetiracetam, Ann Pharmacother March 2007 vol. 41 no. 3 527-528.
14. Pinto A, Sander JW. Levetiracetam: a new therapeutic option for refractory epilepsy. Int J Clin Pract. 2003 Sep;57(7):616-21
15. Naranjo CA, Busto U, Sellers EM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.